NCT06966154
- Conditions
- Disease Attributes, Natural Killer/T-cell Lymphoma, Pathologic Processes, +3 more
- Locations
-
- Dept of lymphoma and medical oncology, Shanghai Cancer Center Shanghai, Shangai, China
Clinical trial condition
Relapsed or Refractory Lymphoma Including ENKL
Explore clinical trials studying Relapsed or Refractory Lymphoma Including ENKL. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study